Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tejnaksh Healthcare Ltd has informed BSE that its Board of Directors will meet on Saturday, 8 November 2025 at Jogeshwari East, Mumbai. The key agenda is to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter ended 30 September 2025, i.e., Q2 FY26 results. The trading window for dealing in the company's shares remains closed until 48 hours after the results are declared. The intimation is filed under Regulation 29 of SEBI LODR Regulations, 2015. No financial figures or outcomes are disclosed in this filing; only the meeting schedule and agenda are communicated.
This is a routine procedural filing ahead of the upcoming Q2 FY26 earnings announcement on 8 November. Investors should watch for the actual results release, which could move the stock. Until then, there is no direct price impact from this intimation itself.